Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol in plasma.
A reversed-phase "high-pressure" liquid-chromatographic method is described for simultaneous analysis for 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol. Separation was optimal with phosphate buffer (50 mmol/L, pH 4.60) as eluent. A simple acid extraction procedure yielded quantitative recoveries and permitted adequate separation for interfering peaks. Compounds were identified by their retention times, absorbance ratios, co-elution with standards, and enzymatic shifts. With a computerized integrator we quantitated these compounds in widely varying concentrations with a single injection. The limit of sensitivity was 0.1 mumol/L for the compounds studied. This method was applied to determine mean values for those compounds in normal human plasma. They are (in mumol/L): uric acid 276 (SD 55), hypoxanthine 0.46 (SD 0.21), xanthine 0.40 (SD 0.27), and uridine 4.50 (SD 1.70). Erythrocytes and platelets can continue to release hypoxanthine and xanthine into plasma or serum after a blood specimen has been drawn. We believe this explains the higher values previously reported for hypoxanthine and xanthine in serum.
D000493:Allopurinol / Q000097:blood*; D001792:Blood Platelets / Q000032:analysis; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004912:Erythrocytes / Q000032:analysis; D005472:Fluorouracil / Q000097:blood; D006801:Humans; D007042:Hypoxanthines / Q000097:blood; D010117:Oxypurinol / Q000097:blood; D011688:Purinones / Q000097:blood*; D011743:Pyrimidines / Q000097:blood*; D014527:Uric Acid / Q000097:blood; D014529:Uridine / Q000097:blood*; D014970:Xanthines / Q000097:blood
D007042:Hypoxanthines; D011688:Purinones; D011743:Pyrimidines; D014970:Xanthines; D014527:Uric Acid; D000493:Allopurinol; D010117:Oxypurinol; D005472:Fluorouracil; D014529:Uridine